glp-1 receptor agonist atrial fibrillation risk Effects of Glucagon-Like Peptide-1 Agonists on Recurrence After Catheter Ablation GLP-1 RAs demonstrate rhythm-protective benefits

This is the same physiologic process seen when someone stops lifting weights: muscle size decreases because the stimulus is gonenot because muscle is being destroyed. Common Misconception: GLP-1 Drugs Burn Muscle Reality: Muscle loss during GLP-1associated weight loss is driven by reduced mechanical load and insufficient protein/calories , not by a toxic or catabolic drug effect. When Lean-Mass Loss Becomes True Muscle Wasting True muscle wasting is uncommon with GLP-1 therapy and is usually related to undernutrition , not the medication itself

Standards of Medical Care in Diabetes2024

is a member of the steering committee of evoke/evoke+ (Novo Nordisk)

22 Because pepsin is the major digestive enzyme in the stomach, SNAC's ability to locally neutralize the pH within the area immediately surrounding the disintegrating tablet stabilizes semaglutide against enzymatic degradation

administration of the glycolysis inhibitor 2-deoxyglucose (2-DG) likewise increases activity of AMPK and blunts food intake suppression by i.c.v.-injected exendin-4 [714]